Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin

Nature Medicine

Volumn 4, Issue 4, 1998, Pages 460-463

  Jevtovic Todorovic V ^a   Todorovic S M ^a   Mennerick, S ^a   Powell, S ^a   Dikranian, K ^a   Benshoff, N ^a   Zorumski, C F ^a   Olney, J W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; DIZOCILPINE; GABAERGIC RECEPTOR AFFECTING AGENT; MUSCARINIC RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N METHYLASPARTIC ACID; NEUROPROTECTIVE AGENT; NEUROTOXIN; NITROUS OXIDE; PENTOBARBITAL; SCOPOLAMINE;

ADOLESCENT; AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; CELL VACUOLE; CINGULATE GYRUS; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; GABAERGIC SYSTEM; INHALATIONAL DRUG ADMINISTRATION; NERVE CELL NECROSIS; NEUROTOXICITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BRAIN; CELLS, CULTURED; DIZOCILPINE MALEATE; FEMALE; GAMMA-AMINOBUTYRIC ACID; HIPPOCAMPUS; MEMBRANE POTENTIALS; N-METHYLASPARTATE; NECROSIS; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXINS; NITROUS OXIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; STEREOISOMERISM;

ANIMALIA;

EID: 2642593034     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0498-460     Document Type: Article

References (25)

1. Franks, N.P. & Lieb, W.R. Molecular and cellular mechanisms of general anaesthesia. Nature 367, 607-614 (1994).
2. Lodge, D. & Anis, N.A. Effects of phencyclidine on excitatory amino acid activation of spinal interneurons in the cat. Eur. J. Pharmacol. 77, 203-204 (1982).
3. Lodge, D. et al. Excitatory amino acids and Phencyclidine-like drugs. In: Excitatory Amino Acid Transmission . Hicks TP, Lodge D and McLennan H (Eds). (New York: Alan R. Liss, Inc), pp 83-90 (1987).
4. Rothman, S.M. The neurotoxicity of excitatory amino acids is produced by passive chloride influx. J. Neurosci. 4, 1483-1489 (1991).
5. Choi, D.W. Glutamate neurotoxicity and disease of the nervous system. Neuron 1, 623-634 (1988).
6. Olney, J.W. Excitatory amino acids and neuropsychiatric disorders. Biol. Psychiatry 26, 505-525 (1989).
7. Olney, J.W., Labruyere, J. & Price, M.T. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244, 1360-1362 (1989).
8. Fix, A.S. et al. Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK(+)801 (Dizocilpine maleate): A light and electron microscopic evaluation of the rat retrosplenial cortex. Exp. Neurol. 123, 204-215 (1993).
9. Farber, N.B. et al. Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: Potential relevance to schizophrenia? Biol. Psychiatry 38 788-796 (1995).
10. Olney, J.W. et al. NMDA antagonist neurotoxicity: Mechanism and prevention. Science 254, 1515-1518 (1991).
11. Ishimaru, M., Fukamauchi, F. & Olney, J.W. Halothane prevents MK-801 neurotoxicity in the rat cingulate cortex. Neurosci. Lett. 193, 1-4 (1995).
12. Jevtovic-Todorovic, V., Kirby, C.O. & Olney, J.W. Isoflurane and propofol block neurotoxicity caused by MK-801 in the rat posterior cingulate/retrosplenial cortex. J. Cereb. Blood Flow and Met. 17, 168-174 (1997).
13. Stevens, R.K. & Scheller, M. Anesthesia as a Speciality: Past, Present and Future. In Clinical Anesthesia, Barash PG et al., Ed. (Philadelphia, JB Lippincott), pp. 6 (1992).
14. Little, H.J. & Thomas, D.L. The effects of anaesthetics and high pressure on the responses of the rat superior cervical ganglion in vitro. J. Physiol. 374, 387-399 (1986).
15. Koblin, D.D., Deady, J.E., Nelson, N.T., Eger, E.I. & Bainton, C.R. Mice tolerant to nitrous oxide are not tolerant to barbiturates. Anesth. Analg. 60, 138-141 (1981).
16. Olney, J.W. & Price, M.T. Excitotoxic amino acids as neuroendocrine research tools. In: Neuroendocrine Peptide Methodology, P. Michael Conn, (Ed.) (San Diego, California: Academic Press), pp.891-905 (1989).
17. Wong, E.H. et al. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc. Natl. Acad. Sci. U.S.A. 83, 7104-7108 (1986).
18. Olney, J.W., Price, M.T., Shahid Salles K., Labruyere, J. & Frierdich, G. MK-801 powerfully protects against N-methyl aspartate neurotoxicity. Eur. J. Pharmacol. 141, 357-361 (1987).
19. Mennerick, S., Que, J., Benz, A. & Zorumski, C.F. Passive and synaptic properties of hippocampal neurons grown in microcultures and in mass cultures. J. Neurophysiology 73, 320-332 (1995).
20. Stevens, W.C. & Kingston, H.G.G. Inhalation Anesthesia. In Clinical Anesthesia, Barash, P.G. et al., (Ed.) (Philadelphia, JB Lippincott), 439-465 (1992).
21. Fragen, R.J. & Avram, M.J. Nonopioid Intravenous Anesthetics. In Clinical Anesthesia, Barash, P.G. et al., (Eds.) (Philadelphia: JB Lippincott), 385-412 (1992).
22. Hornbein, T.F. et al. The minimum alveolar concentration of nitrous oxide in man. Anest. Analg. 61, 553-556 (1982).
23. Gonsowski, C.T. & Eger II, E.I. Nitrous oxide minimum alveolar anesthetic concentration in rats is greater than previously reported. Anesth. Analg. 79, 710-712 (1994).
24. Mahmoudi, N.W., Cole, D.J. & Shapiro, H.M. Insufficient anesthetic potency of nitrous oxide in the rat. Anesthesiology 70, 345 (1989).
25. Dohrn, C.S. et al. Reinforcing effects of extended inhalation of nitrous oxide in humans. Drug Alcohol Depend. 31, 265-280 (1993).